Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $90.78 +1.18%
Revenue Growth %: +11.1%
Financial Fact:
Income before provision for income taxes: 185.2M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +11.1%
Financial Fact:
Income before provision for income taxes: 185.2M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $888.5 million versus the consensus estimate of $867.09 million.
GUIDANCE:
Edwards Lifesciences sees Q1 2018 EPS of $1.04-$1.14. Edwards Lifesciences sees Q1 2018 revenue of $3.5-3.9 billion.
Edwards Lifesciences sees FY2018 EPS of $4.43-$4.63. Edwards Lifesciences sees FY2018 revenue of $900-950 million.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
